regulates calcium, vital for bone health and bodily functions
Associated with: - Gastric Autoimmunity - Chronic Atrophic Gastritis - Pernicious Anemia
present in animal models for Sjogren's syndrome (SS) and patients with the disease.
present in animal models for Sjogren's syndrome (SS) and patients with the disease.
present in animal models for Sjogren's syndrome (SS) and patients with the disease.
Lyme disease and Parovirus B19 infections produce arthritis, rashes, and a systemic illness that may be thought to represent a chronic rheumatic disease. Cases of co infections have also been reported in literature. Additionally, it has been shown to be a good candidate for differential diagnosis in cases of arthopathy where Lyme disease has been suspected.
The presence of IgG antibodies only is indicative of past exposure to Parvovirus.
The presence of IgM class antibodies suggests recent infection.
What is Parvovirus B19 VLP VP1/VP2 Co-Capsid – IgG? Parvovirus B19 is a common human virus that causes fifth disease (also known as erythema infectiosum), especially in children. It typically presents with a “slapped cheek” facial rash and mild flu-like symptoms. In adults, it can cause joint pain or arthritis-like symptoms, and in vulnerable individuals—such as pregnant women, immunocompromised patients, or those with chronic anemia—it can lead to more serious complications, including fetal infection or severe anemia. The VP1/VP2 Co-Capsid IgG test detects IgG antibodies to the virus-like particle (VLP) capsid proteins VP1 and VP2 of Parvovirus B19. These are the major structural proteins that form the virus’s outer shell. When your immune system recognizes these proteins, it produces IgG antibodies that typically remain in the bloodstream for many months or years—indicating past infection and likely immunity.
What is Parvovirus B19 VLP VP1/VP2 Co-Capsid – IgM? Parvovirus B19 is a common virus that causes fifth disease (also known as erythema infectiosum), particularly in children. It often presents with a red rash on the cheeks (“slapped cheek” appearance) and mild flu-like symptoms. In adults, it may cause joint pain or fatigue. In certain cases—especially among pregnant women, people with weakened immune systems, or those with chronic anemia—Parvovirus B19 infection can lead to more serious complications, such as fetal infection or severe anemia. The VP1/VP2 Co-Capsid – IgM test detects IgM antibodies to the virus-like particle (VLP) capsid proteins VP1 and VP2, which are structural proteins of the virus. IgM antibodies are the first type of antibodies the immune system produces after an infection and typically appear within 1 to 2 weeks of exposure. This test helps identify recent or current infection with Parvovirus B19.
What is Parvovirus B19 VLP VP2 – IgG? Parvovirus B19 is a common virus that causes a mild childhood illness known as fifth disease or erythema infectiosum, which typically presents with a “slapped cheek” rash and low-grade fever. In adults, infection may lead to joint pain or flu-like symptoms. In some cases—particularly in people with weakened immune systems, certain blood disorders, or during pregnancy—Parvovirus B19 can lead to more serious complications, such as anemia or fetal infection. The VLP VP2 – IgG test detects IgG antibodies against the virus-like particle (VLP) of the VP2 protein, one of the main structural proteins of Parvovirus B19. IgG antibodies usually develop a few weeks after infection and remain in the bloodstream long-term, indicating past exposure and likely immunity.
Low levels of pathogens can be normal and characteristic of a healthy, diverse gut microbiome. Increased levels of pathogens, however, could indicate that a pathogen is playing a role in symptoms you are experiencing. The Pathogen Control Index compares the relative abundances (RA) of specific pathogens to normal levels present in the healthy gut. Note: BiomeFx is NOT a diagnostic test. If your Pathogen Control Index is low, consult your physician who can make a diagnosis and provide treatment if needed.
a toxic chemical contaminant produced by several species of mold.
What is Patulin? Patulin is a mycotoxin produced by several molds, primarily Aspergillus, Byssochlamys, and Penicillium. It is most often linked to blue mold contamination of fruit, especially apples and apple-derived products such as juice, cider, applesauce, and purees. Patulin is heat-stable, meaning it can survive many food processing steps. As a result, exposure typically occurs through the dietary intake of contaminated fruit-based foods. Because of its potential health risks, many countries have established strict safety limits for patulin in commercial apple products. Why Does Patulin Exposure Matter? Patulin is toxic to multiple body systems and may cause: Digestive problems: nausea, vomiting, diarrhea, abdominal pain Neurological effects: headaches, fatigue, difficulty concentrating Immune suppression: reduced resistance to infections, slower healing Developmental risks: possible interference with fetal growth during pregnancy with chronic exposure Oxidative stress: cell and tissue damage from increased free radicals Genotoxicity: potential DNA damage, raising concern for long-term cancer risk (though direct human evidence is limited) Children are considered especially vulnerable, which is why regulatory agencies enforce very low allowable levels in apple juice, cider, and related products. Health Effects of Patulin Studies link both acute and chronic patulin exposure to: Digestive symptoms: nausea, vomiting, abdominal pain, diarrhea Neurological symptoms: headaches, fatigue, irritability, impaired concentration Immune dysfunction: higher infection rates, slower recovery times Organ stress: liver, kidney, and intestinal toxicity seen in animal studies Long-term concerns: DNA damage, developmental effects, and possible carcinogenic potential Why Test for Patulin? A urine patulin test can be useful if you: Regularly consume apples, apple juice, cider, or other apple-based products Experience persistent digestive issues, headaches, or fatigue Live in regions where fruit storage conditions favor mold growth Are completing a Mycotoxins or Total Tox Burden panel Want to track detoxification progress or confirm whether dietary changes lower exposure Key Takeaway Elevated patulin in urine reflects recent dietary exposure to mold-contaminated fruits, most often apples and apple juice. While small exposures are usually harmless, ongoing or high levels may contribute to digestive issues, immune suppression, and neurological symptoms. To reduce risk: Choose high-quality, undamaged fruit Avoid moldy or bruised produce Buy apple-based products from trusted sources that comply with food safety standards These steps can help lower patulin exposure and support your long-term health.
What is PBG Deaminase? PBG Deaminase (also called porphobilinogen deaminase, uroporphyrinogen I synthase, or hydroxymethylbilane synthase) is a key enzyme in the heme biosynthesis pathway — the process by which your body makes heme, a vital component of hemoglobin, myoglobin, and other important proteins. Heme is essential for transporting oxygen in the blood and for many cellular processes, including energy production and detoxification. PBG Deaminase is the third enzyme in this pathway and plays a critical role in converting porphobilinogen (PBG) into hydroxymethylbilane, which eventually becomes heme. Why is PBG Deaminase Measured in Whole Blood? The PBG Deaminase, WB test measures the activity of the PBG Deaminase enzyme in red blood cells. Measuring enzyme activity in whole blood helps detect certain inherited disorders of heme metabolism, especially acute intermittent porphyria (AIP). Clinical Relevance: Acute Intermittent Porphyria (AIP) AIP is a rare genetic metabolic disorder caused by a partial deficiency of PBG Deaminase. People with AIP cannot properly break down porphyrin precursors, leading to a buildup of toxic substances like ALA (aminolevulinic acid) and PBG in the body. This can cause serious and sometimes life-threatening symptoms, particularly affecting the nervous system. Symptoms of AIP May Include: Sudden, severe abdominal pain (without clear cause) Muscle weakness or paralysis Anxiety, confusion, or hallucinations Seizures Rapid heart rate or high blood pressure Dark-colored urine (due to excess porphyrins) Attacks are often triggered by medications, fasting, stress, infection, or hormonal changes. Identifying low PBG Deaminase activity helps confirm a diagnosis, especially when paired with elevated levels of ALA and PBG in the urine during an attack. What Does an Abnormal Result Mean? Low PBG Deaminase Activity Strongly suggests AIP, particularly when symptoms and other porphyrin-related tests align. May also indicate a silent genetic carrier (someone with a mutation who may never have symptoms but can pass it on to offspring). Important for family screening—AIP is inherited in an autosomal dominant pattern, meaning only one copy of the gene mutation is needed to be at risk. Normal or High Activity Makes AIP unlikely, especially if other tests (urinary ALA, PBG) are also normal. Other types of porphyria or conditions with similar symptoms may need to be ruled out. Who Should Be Tested? Testing PBG Deaminase activity is typically recommended for individuals who: Have symptoms suggestive of AIP Have family members with AIP Have had positive urine porphyrin screening tests Are undergoing differential diagnosis for unexplained abdominal pain and neurological symptoms Important Notes About the Test Sample type: Whole blood, typically collected in EDTA tubes. The enzyme is heat-sensitive, so the sample must be kept cold and processed quickly to avoid degradation. Results should be interpreted in the context of clinical symptoms, family history, and other porphyrin-related tests. Follow-Up and Management If PBG Deaminase activity is low and AIP is diagnosed: Your healthcare provider may recommend genetic testing to identify specific mutations. You may need to avoid triggering medications, manage stress, and maintain a balanced diet to prevent acute attacks. In some cases, heme arginate or glucose infusions are used to treat attacks. Summary PBG Deaminase, WB is a specialized enzyme test used primarily to diagnose acute intermittent porphyria (AIP) — a rare but serious disorder of heme synthesis. Low enzyme activity confirms the presence of a genetic defect affecting heme metabolism, often requiring lifestyle adjustments and medical supervision to prevent dangerous metabolic crises.
The "PBG/Creatinine Ratio" marker found on a Porphobilinogen, Quantitative, Random Urine panel by LabCorp is a crucial test for evaluating the presence and concentration of porphobilinogen (PBG) in urine in relation to creatinine levels. This test is significant for diagnosing and monitoring conditions related to abnormal porphyrin metabolism, such as acute intermittent porphyria, among others. Porphyria refers to a group of disorders that result from a buildup of natural chemicals that produce porphyrin in your body. Porphobilinogen is a precursor in the biosynthesis of heme, the iron-containing prosthetic group found in hemoglobin. Normally, the body regulates the production of porphobilinogen and other intermediates in the heme production pathway. However, genetic conditions can disrupt this balance, leading to the accumulation of toxic precursors like PBG. Measuring the PBG/Creatinine Ratio is particularly useful because it helps normalize the PBG level to the amount of creatinine in the urine, providing a more accurate assessment of the body's porphyrin metabolism than measuring PBG levels alone. Creatinine is a waste product produced by muscles from the breakdown of a compound called creatine. Creatinine levels in the urine can vary based on muscle mass, hydration status, and kidney function. By comparing PBG levels to creatinine levels, healthcare providers can obtain a clearer picture of the body's chemical balance and more accurately diagnose and manage porphyria and related metabolic conditions.